drugset / Trial / NCT06021067

Dead Mesenchymal Stem Cells for Radiation Lung Injury

NCT06021067 ↗

Phase 1/2 Unknown 15 enrolled Sichuan University
NaSingle-groupOpen-labelTreatment

Summary

The aim of this single center, single arm and prospective study is to explore the safety and efficacy of hDMSCs in the treatment of radiation pneumonitis.

Timeline

Start
2023-09-10
Primary completion
2024-09-10
Completion
2024-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Death mesenchymal stem cell Cell therapy 2e+07 cells Other
Subject Death mesenchymal stem cell Cell therapy 6e+07 cells Other

Indications